Michael Shetzline, CMO, SVP, Head-Res&Drug at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 33,906 shares at $11.41 ($385K) on 2023-02-27, disclosed to the SEC on 2023-03-01.
Open-market sale of $385k IRWD by CMO, SVP, Head-Res&Drug. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.41 | 2,322 | $26K | 6.9% |
| 2 | $11.41 | 7,146 | $82K | 21.2% |
| 3 | $11.41 | 7,146 | $82K | 21.2% |
| 4 | $11.31 | 2,416 | $27K | 7.1% |
| 5 | $11.31 | 7,438 | $84K | 21.8% |
| 6 | $11.31 | 7,438 |
| $84K |
| 21.8% |
| Total | $11.36 avg | 33,906 | $385K | 100% |
| Filing → |
| IRWD | SELL | 2024-05-22 | $208K | — | Filing → |
| IRWD | SELL | 2024-02-14 | $1.2M | — | Filing → |
| IRWD | SELL | 2023-05-24 | $209K | — | Filing → |